Cetuximab as last-line treatment for rmHNSCC outside clinical trials. A retrospective DAHANCA study

J. G. Eriksen; Sofie Lunden Nielsen; K. Bjerg  Andersen; A. Qasim Ali Mohamed; Kinga Nowicka-Matus

Cetuximab as last-line treatment for rmHNSCC outside clinical trials. A retrospective DAHANCA study

J. G. Eriksen, Sofie Lunden Nielsen, K. Bjerg Andersen, A. Qasim Ali Mohamed, Kinga Nowicka-Matus

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	PO-0178
Journal	Radiotherapy & Oncology
Volume	168
Issue number	Suppl. 1
Pages (from-to)	S112-113
ISSN	0167-8140
Publication status	Published - Mar 2022
Event	ICHNO-ECHNO 2022 - Onsite and online, Bruxelles, Belgium Duration: 3 Mar 2022 → 5 Mar 2022

Conference

Conference	ICHNO-ECHNO 2022
Location	Onsite and online
Country/Territory	Belgium
City	Bruxelles
Period	03/03/2022 → 05/03/2022

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

@article{c1ff9c9eb6d34a3583916a1f4589eb56,

title = "Cetuximab as last-line treatment for rmHNSCC outside clinical trials. A retrospective DAHANCA study",

author = "Eriksen, {J. G.} and Nielsen, {Sofie Lunden} and Andersen, {K. Bjerg} and Mohamed, {A. Qasim Ali} and Kinga Nowicka-Matus",

year = "2022",

month = mar,

language = "English",

volume = "168",

pages = "S112--113",

journal = "Radiotherapy & Oncology",

issn = "0167-8140",

publisher = "Elsevier",

number = "Suppl. 1",

note = "ICHNO-ECHNO 2022, ICHNO ; Conference date: 03-03-2022 Through 05-03-2022",

}

TY - ABST

T1 - Cetuximab as last-line treatment for rmHNSCC outside clinical trials. A retrospective DAHANCA study

AU - Eriksen, J. G.

AU - Nielsen, Sofie Lunden

AU - Andersen, K. Bjerg

AU - Mohamed, A. Qasim Ali

AU - Nowicka-Matus, Kinga

PY - 2022/3

Y1 - 2022/3

UR - https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiJ0afRs_b8AhX4SPEDHRnADEcQFnoECA4QAQ&url=https%3A%2F%2Fuser-swndwmf.cld.bz%2FICHNO-ECHNO-2022-Abstract-Book&usg=AOvVaw2fmNW6VPi7f-DqD6t8Oul_

M3 - Conference abstract in journal

SN - 0167-8140

VL - 168

SP - S112-113

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

IS - Suppl. 1

M1 - PO-0178

T2 - ICHNO-ECHNO 2022

Y2 - 3 March 2022 through 5 March 2022

ER -

Cetuximab as last-line treatment for rmHNSCC outside clinical trials. A retrospective DAHANCA study

Conference

AUB Link

Other files and links

Cite this